Weight-based ribavirin with pegylated interferon alfa 2b: benefits, risks, and the origin of the evidence
- PMID: 12812198
- DOI: 10.1016/s0016-5085(03)00576-6
Weight-based ribavirin with pegylated interferon alfa 2b: benefits, risks, and the origin of the evidence
Comment on
-
Impact of pegylated interferon alfa-2b and ribavirin on liver fibrosis in patients with chronic hepatitis C.Gastroenterology. 2002 May;122(5):1303-13. doi: 10.1053/gast.2002.33023. Gastroenterology. 2002. PMID: 11984517
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical